Cargando…
UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology
Breast cancer has the highest incidence and death rate among cancers in women worldwide. In particular, metastatic estrogen receptor negative (ER–) breast cancer and triple-negative breast cancer (TNBC) subtypes have very limited treatment options, with low survival rates. Ubiquitin carboxyl termina...
Autores principales: | Mondal, Milon, Conole, Daniel, Nautiyal, Jaya, Tate, Edward W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727673/ https://www.ncbi.nlm.nih.gov/pubmed/34497382 http://dx.doi.org/10.1038/s41416-021-01516-5 |
Ejemplares similares
-
Recent Developments in Cell Permeable Deubiquitinating Enzyme Activity-Based Probes
por: Conole, Daniel, et al.
Publicado: (2019) -
Discovery
of a Potent and Selective Covalent Inhibitor
and Activity-Based Probe for the Deubiquitylating Enzyme UCHL1, with
Antifibrotic Activity
por: Panyain, Nattawadee, et al.
Publicado: (2020) -
Correction to “Discovery of a Potent and Selective
Covalent Inhibitor and Activity-Based Probe for the Deubiquitylating
Enzyme UCHL1, with Antifibrotic Activity”
por: Panyain, Nattawadee, et al.
Publicado: (2020) -
Molecular Characterization and Expression Profiles of Sp-uchl3 and Sp-uchl5 during Gonad Development of Scylla paramamosain
por: Han, Kunhuang, et al.
Publicado: (2018) -
Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP-PROTACs)
por: Zhang, Qisi, et al.
Publicado: (2022)